Brief: Dr. Lal Pathlabs Says NCLT Sanctioned Scheme Of Amalgamation With Delta Ria And Pathology
14/12/2018 07:29
Dec 14 (Reuters) - Dr. Lal PathLabs Ltd DLPA.NS :
* NCLT SANCTIONED SCHEME OF AMALGAMATION BETWEEN CO AND
DELTA RIA
AND PATHOLOGY PVT LTD
Source text: http://bit.ly/2S1Ewmm
Further company coverage: DLPA.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Dr. Lal PathLabs
See all newsBrief: Lal Pathlabs Says Unit Acquired Remaining 30% Equity Stake In Centrapath Labs Private Limited
India's Dr Lal PathLabs rises as Axis Securities initiates with 'buy'
India's Dr Lal PathLabs rises; analysts back SN Genelab deal
Brief: Lal Pathlabs Says Subsidiary Incorporated Dr Lal Pathlabs Indomed In Tashkent, Uzbekistan
India's Dr Lal PathLabs jumps to 4-year high after quarterly profit rise